AI assistant
Sending…
BROADRIDGE FINANCIAL SOLUTIONS, INC. — Director's Dealing 2021
Aug 6, 2021
30171_dirs_2021-08-06_76a61319-1222-4f3d-a3d2-3d8e046609f7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 5 — Annual Statement of Changes in Beneficial Ownership
Issuer: BROADRIDGE FINANCIAL SOLUTIONS, INC. (BR)
CIK: 0001383312
Period of Report: 2021-06-30
Reporting Person: Liberatore Michael (VP, ICS - Mutual Funds)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-09-11 | Common Stock | P | 25.0000 | $134.5212 | Acquired | 11684.9100 | Direct |
| 2020-11-02 | Common Stock | S | 25.0000 | $140.2150 | Disposed | 11659.9100 | Direct |
| 2020-09-11 | Common Stock | P | 40.0000 | $134.4357 | Acquired | 40.0000 | Indirect |
| 2020-11-02 | Common Stock | S | 40.0000 | $140.3335 | Disposed | 0.0000 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $50.9500 | 2025-02-09 | Common Stock (1806.0000) | 1806.0000 | Direct |
| Stock Option (Right to Buy) | $51.9500 | 2026-02-08 | Common Stock (5259.0000) | 5259.0000 | Direct |
| Stock Option (Right to Buy) | $67.3200 | 2027-02-10 | Common Stock (8100.0000) | 8100.0000 | Direct |
| Stock Option (Right to Buy) | $93.8800 | 2028-02-12 | Common Stock (7760.0000) | 7760.0000 | Direct |
| Stock Option (Right to Buy) | $98.3100 | 2029-02-11 | Common Stock (8196.0000) | 8196.0000 | Direct |
| Stock Option (Right to Buy) | $117.3400 | 2030-02-04 | Common Stock (8357.0000) | 8357.0000 | Direct |
| Stock Option (Right to Buy) | $148.0700 | 2031-02-12 | Common Stock (6547.0000) | 6547.0000 | Direct |
More from BROADRIDGE FINANCIAL SOLUTIONS, INC.
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 4
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 25
Director's Dealing
2026
Feb 12
Regulatory Filings
2026
Feb 7